logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

Daisuke Takahari

Department of Gastroenterological Chemotherapy
H指数:32
被引数:4,590

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1

PD-L1表达和未经免疫检查点抑制剂治疗的不可切除/复发性胃癌一线治疗后的生存情况：JCOG1013A1研究

British Journal of Cancer
IF6.8
2026-09-040
OAAI
Hidekazu Hirano; Yasuhide Yamada; Kengo Nagashima; Nobuyoshi Hiraoka; Shigeki Sekine; Naoki Takahashi; Mizutomo Azuma; Satoru Iwasa; Keisuke Kanato; Nozomu Machida; Takahiro Kinoshita; Hiroaki Hata; Hisato Kawakami; Daisuke Takahari; Toshiyasu Ojima; Shigenori Kadowaki; Narikazu Boku; Yukinori Kurokawa; Masanori Terashima; Takaki Yoshikawa
Usefulness of pharmacy outpatient clinic follow-up for maintaining relative dose intensity in patients on adjuvant CAPOX chemotherapy for gastric cancer

胃癌辅助CAPOX化疗患者中药房门诊随访对维持相对剂量强度的作用

Molecular and Clinical Oncology
IF1.4
2026-05-010
PRE
Nakamura, Masashi; Yokokawa, Takashi; Kawakami, Kazuyoshi; Kimura, Yuka; Shimizu, Hisanori; Kobayashi, Kazuo; Aoyama, Takeshi; Suzuki, Wataru; Hatori, Masahiro; Suzuki, Kenichi; Takahari, Daisuke; Ogura, Mariko; Chin, Keisho; Wakatsuki, Takeru; Yamaguchi, Kensei; Yamaguchi, Masakazu
Therapeutic value of para-aortic lymph node dissection in gastric cancer with extensive lymph node metastasis: integrated analysis of three phase II trials (JCOG2212A)

腹膜后淋巴结清扫在广泛淋巴结转移的胃癌中的治疗价值：三项II期临床试验的整合分析（JCOG2212A）

Gastric Cancer
IF5.1
2026-04-270
PRE
Takeyuki Wada; Masayuki Yokoyama; Seiji Ito; Tadayoshi Hashimoto; Kota Kawabata; Kazuhisa Ehara; Takashi Nomura; Masaki Aizawa; Ryohei Kawabata; Daisuke Takahari; Mitsuru Sasako; Akira Tsuburaya; Takeshi Sano; Masanori Terashima; Narikazu Boku; Yukinori Kurokawa; Takaki Yoshikawa
Increased treatment options and improved survival in real-world patients with HER2-positive advanced gastric cancer from 2011 to 2023

HER2阳性晚期胃癌患者真实世界中的治疗选择增加和生存改善（2011年至2023年）

Therapeutic Advances in Gastroenterology
IF3.4
2026-04-110
PRE
Keitaro Shimozaki; Akira Ooki; Kaoru Yoshikawa; Koichiro Yoshino; Shohei Udagawa; Hiroki Osumi; Shota Fukuoka; Takeru Wakatsuki; Mariko Ogura; Daisuke Takahari; Eiji Shinozaki; Keisho Chin; Kensei Yamaguchi
Clinical impact of intratumoral HER2 heterogeneity on trastuzumab deruxtecan efficacy in patients with HER2-positive gastric cancer

HER2阳性胃癌患者中肿瘤内HER2异质性对曲妥珠单抗德鲁替康疗效的临床影响

Gastric Cancer
IF5.1
2026-04-020
OAAI
Koichiro Yoshino; Manabu Takamatsu; Akira Ooki; Keisho Chin; Daisuke Takahari; Hiroki Osumi; Mariko Ogura; Mikako Tamba; Koshiro Fukuda; Keitaro Shimozaki; Shohei Udagawa; Shota Fukuoka; Eiji Shinozaki; Kensei Yamaguchi; Takeru Wakatsuki
Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer

基于拷贝数分析的癌基因主导性可能提示ERBB2依赖性及曲妥珠单抗应答在HER2阳性胃癌中的情况

Targeted Oncology
IF4
2026-03-150
OAAI
Takeru Wakatsuki; Noriko Yamamoto; Naoki Ishizuka; Shuichi Hironaka; Keiko Minashi; Shigenori Kadowaki; Hidekazu Hirano; Hirokazu Shoji; Toshifumi Yamaguchi; Keisho Chin; Mariko Ogura; Izuma Nakayama; Hiroki Osumi; Arisa Ueki; Shigehisa Kitano; Narikazu Boku; Kensei Yamaguchi; Daisuke Takahari
Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High)

循环肿瘤DNA在HER2阳性晚期胃癌中的临床意义：一项关于HER2和PD-1双靶向疗法（Ni-High）的 Ib 期临床试验的协作研究

Therapeutic Advances in Medical Oncology
IF4.2
2025-09-120
OA
Hiroki Osumi; Takeru Wakatsuki; Akira Ooki; Keisho Chin; Hirokazu Shoji; Mariko Ogura; Izuma Nakayama; Noriko Yamamoto; Hidekazu Hirano; Hiroki Hara; Keiko Minashi; Eiji Shinozaki; Ken Kato; Naoki Ishizuka; Shigehisa Kitano; Kengo Takeuchi; Narikazu Boku; Kensei Yamaguchi; Daisuke Takahari
A phase I/II trial evaluating the safety of increased-dose S-1 with oxaliplatin and nivolumab in HER2-negative advanced gastric cancer

I/II期临床试验评估奥沙利铂和纳武单抗增加剂量S-1在HER2-negative晚期胃癌中的安全性

BMC CANCER
IF3.4
2025-04-120
OAAI
Baba, Keisuke; Suzuki, Nobumi; Imamura, Chiyo K.; Booka, Eisuke; Takeuchi, Masashi; Takahari, Daisuke; Kawakami, Takeshi; Kawakubo, Hirofumi; Kitagawa, Chiyoe; Kono, Yoshiyasu; Ogura, Keiji; Kito, Yosuke; Saito, Kei; Yamamoto, Shinzo; Takeuchi, Hiroya; Kudo, Toshihiro; Tsunoda, Takuya; Mizukami, Takuro; Yamaguchi, Toshifumi; Shoji, Hirokazu; Saito, Kanako; Tanoue, Kenro; Baba, Eishi; Nagashima, Kengo; Boku, Narikazu
Investigating the role of immunotherapy for real-world patients with HER2-negative advanced gastric cancer between 2011 and 2023

调查2011年至2023年间免疫疗法在HER2阴性晚期胃癌真实世界患者中的作用

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2025-02-240
OA
Keitaro Shimozaki; Akira Ooki; Koichiro Yoshino; Mikako Tamba; Shohei Udagawa; Hiroki Osumi; Shota Fukuoka; Izuma Nakayama; Takeru Wakatsuki; Mariko Ogura; Daisuke Takahari; Eiji Shinozaki; Keisho Chin; Kensei Yamaguchi
Phase II trial of nab-paclitaxel plus ramucirumab in combination with nivolumab for unresectable advanced or recurrent gastric cancer after progression on first-line treatment including fluoropyrimidine, platinum, and anti-PD-1/PD-L1 antibody (PADDLE)

nab-紫杉醇联合雷莫芦单抗联合nivolumab治疗一线治疗进展后不可切除的晚期或复发性胃癌的II期试验，包括氟嘧啶，铂和anti-PD-1/PD-L1抗体 (PADDLE)

BMC CANCER
IF3.4
2025-02-040
OAAI
Hirano, Hidekazu; Takahashi, Naoki; Amanuma, Yusuke; Suzuki, Nobumi; Takahari, Daisuke; Kawakami, Takeshi; Kudo-Saito, Chie; Nagashima, Kengo; Boku, Narikazu; Kato, Ken; Shoji, Hirokazu
Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023

食管胃结合部癌临床实践指南: 上消化道肿瘤峰会2023

GASTRIC CANCER
IF5.1
2024-02-226
OAAI
Kitagawa, Yuko; Matsuda, Satoru; Gotoda, Takuji; Kato, Ken; Wijnhoven, Bas; Lordick, Florian; Bhandari, Pradeep; Kawakubo, Hirofumi; Kodera, Yasuhiro; Terashima, Masanori; Muro, Kei; Takeuchi, Hiroya; Mansfield, Paul F.; Kurokawa, Yukinori; So, Jimmy; Monig, Stefan Paul; Shitara, Kohei; Rha, Sun Young; Janjigian, Yelena; Takahari, Daisuke; Chau, Ian; Sharma, Prateek; Ji, Jiafu; de Manzoni, Giovanni; Nilsson, Magnus; Kassab, Paulo; Hofstetter, Wayne L.; Smyth, Elizabeth Catherine; Lorenzen, Sylvie; Doki, Yuichiro; Law, Simon; Oh, Do-Youn; Ho, Khek Yu; Koike, Tomoyuki; Shen, Lin; van Hillegersberg, Richard; Kawakami, Hisato; Xu, Rui-Hua; Wainberg, Zev; Yahagi, Naohisa; Lee, Yeong Yeh; Singh, Rajvinder; Ryu, Min-Hee; Ishihara, Ryu; Xiao, Zili; Kusano, Chika; Grabsch, Heike Irmgard; Hara, Hiroki; Mukaisho, Ken-ichi; Makino, Tomoki; Kanda, Mitsuro; Booka, Eisuke; Suzuki, Sho; Hatta, Waku; Kato, Motohiko; Maekawa, Akira; Kawazoe, Akihito; Yamamoto, Shun; Nakayama, Izuma; Narita, Yukiya; Yang, Han-Kwang; Yoshida, Masahiro; Sano, Takeshi
Clinical Impact of ERBB2 copy number and tumor mutation burden (TMB) in patients with HER2-positive advanced gastric cancer treated by nivolumab (N-mab) plus trastuzumab (T-mab) and standard chemotherapy
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
PRE
Shoji, H.; Wakatsuki, T.; Takahari, D.; Yamamoto, N.; Ooki, A.; Chin, K.; Kurihara, N.; Kiyotani, K.; Mashima, T.; Ogura, M.; Nakayama, I.; Minashi, K.; Hara, H.; Shinozaki, E.; Ishizuka, N.; Kitano, S.; Seimiya, H.; Takeuchi, K.; Boku, N.; Yamaguchi, K.
APC mutation (mt.), MYC, and GATA6 amplifications (amp.) were associated with worse survival in HER2-positive advanced gastric cancer patients treated with S-1/ capecitabine plus oxaliplatin combined with trastuzumab (Tmab) and nivolumab (N-mab)
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
OA
Wakatsuki, T.; Takahari, D.; Yamamoto, N.; Ooki, A.; Chin, K.; Kurihara, N.; Mashima, T.; Ogura, M.; Nakayama, I.; Fukuoka, S.; Hirano, H.; Minashi, K.; Hara, H.; Kato, K.; Ishizuka, N.; Kitano, S.; Seimiya, H.; Takeuchi, K.; Boku, N.; Yamaguchi, K.
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study
GASTRIC CANCER
IF5.1
2023-08-231
OAAI
Kawabata, Ryohei; Chin, Keisho; Takahari, Daisuke; Hosaka, Hisashi; Muto, Osamu; Shindo, Yoshiaki; Nagata, Naoki; Yabusaki, Hiroshi; Imamura, Hiroshi; Endo, Shunji; Kashiwada, Tomomi; Nakamura, Masato; Hihara, Jun; Kobayashi, Michiya; Sagawa, Tamotsu; Saito, Soh; Sato, Atsushi; Yamada, Takeshi; Okano, Naohiro; Shimada, Ken; Matsushima, Masashi; Kataoka, Masato; Matsumoto, Shigemi; Goto, Masahiro; Kotaka, Masahito; Shiraishi, Takeshi; Yamai, Hiromichi; Nagashima, Fumio; Ishizuka, Naoki; Yamaguchi, Kensei
Single-organ pulmonary metastasis is a favorable prognostic factor in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors

单器官肺转移是接受FOLFIRI和血管内皮生长因子抑制剂治疗的转移性结直肠癌患者的有利预后因素

BMC CANCER
IF3.4
2023-07-061
OAAI
Fukuda, Koshiro; Osumi, Hiroki; Yoshino, Koichiro; Nakayama, Izuma; Fukuoka, Shota; Ogura, Mariko; Wakatsuki, Takeru; Ooki, Akira; Takahari, Daisuke; Chin, Keisho; Yamaguchi, Kensei; Shinozaki, Eiji

研究方向

暂未获取到该数据
K
Kensei Yamaguchi
H 指数:65论文数:921被引数:2.2万
T
Takeru Wakatsuki
H 指数:24论文数:371被引数:2,544
I
Izuma Nakayama
H 指数:18论文数:212被引数:1,727
K
Kei Muro
H 指数:80论文数:1,040被引数:4.4万
K
Keisho Chìn
H 指数:41论文数:329被引数:1.1万
M
Mariko Ogura
H 指数:19论文数:208被引数:1,563
H
Hiroki Osumi
H 指数:20论文数:189被引数:1,585
T
Takashi Ura
H 指数:32论文数:244被引数:5,074
K
Kohei Shitara
H 指数:79论文数:1,129被引数:3.5万
E
Eiji Shinozaki
H 指数:29论文数:345被引数:3,474